Dexcom (DXCM) EPS (Weighted Average and Diluted) (2013 - 2026)
Dexcom (DXCM) reported EPS (Weighted Average and Diluted) of $0.51 for Q1 2026, up 88.89% year-over-year from $0.27 in Q1 2025, and down 23.88% on a QoQ basis from $0.67 in Q4 2025.
Dexcom (DXCM) has 14 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.51 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 88.89% year-over-year to $0.51 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.33 (up 73.88% YoY) and the FY2025 annual result came in at $2.09, up 47.18% from the prior year.
- EPS (Weighted Average and Diluted) fell to $0.51 in Q1 2026 per DXCM's latest filing, from $0.67 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.7 in Q3 2025 and bottomed at $0.12 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is $0.34 (2024), against an average of $0.36.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 2300.0% in 2022, while the deepest fall reached 58.93% in 2022.
- Tracing DXCM's EPS (Weighted Average and Diluted) over 5 years: stood at $0.22 in 2022, then soared by 177.27% to $0.61 in 2023, then slumped by 37.7% to $0.38 in 2024, then surged by 76.32% to $0.67 in 2025, then declined by 23.88% to $0.51 in 2026.
- Per Business Quant, the three latest DXCM EPS (Weighted Average and Diluted) figures stand at $0.51 (Q1 2026), $0.67 (Q4 2025), and $0.7 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.51 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 0.70 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.35 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.61 |
| Sep 30, 2023 | 0.29 |
| Jun 30, 2023 | 0.28 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.22 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | 0.21 |
| Jun 30, 2021 | 0.19 |
| Mar 31, 2021 | 0.56 |
| Dec 31, 2020 | -0.10 |
| Sep 30, 2020 | 0.73 |
| Jun 30, 2020 | 0.48 |
| Mar 31, 2020 | 0.21 |
| Dec 31, 2019 | 1.00 |
| Sep 30, 2019 | 0.50 |
| Jun 30, 2019 | -0.12 |
| Mar 31, 2019 | -0.30 |
| Dec 31, 2018 | -2.03 |
| Sep 30, 2018 | 0.52 |
| Jun 30, 2018 | 0.34 |
| Mar 31, 2018 | -0.28 |
| Dec 31, 2017 | -0.11 |
| Sep 30, 2017 | -0.02 |
| Jun 30, 2017 | 0.03 |
| Jun 30, 2016 | -0.24 |
| Sep 30, 2015 | -0.53 |
| Jun 30, 2015 | -0.05 |
| Sep 30, 2014 | -0.08 |
| Jun 30, 2014 | -0.09 |
| Sep 30, 2013 | -0.08 |
| Jun 30, 2013 | -0.14 |